Investors Can Join Class Action Lawsuit Against Hims & Hers Health, Inc. for Securities Fraud

Investors Have a Chance to Lead a Class Action Lawsuit Against Hims & Hers Health, Inc.

On June 30, 2025, The Schall Law Firm, a prominent national litigation firm specializing in shareholder rights, issued a reminder regarding a class action lawsuit against Hims & Hers Health, Inc. (NYSE: HIMS). This lawsuit has been initiated due to apparent violations of the Securities Exchange Act of 1934, specifically concerning §§10(b) and 20(a) along with Rule 10b-5, as enforced by the U.S. Securities and Exchange Commission (SEC).

Background of the Case

The class action lawsuit focuses on investors who purchased Hims & Hers securities from April 29 to June 23, 2025—a timeframe during which serious allegations regarding the company’s marketing tactics emerged. Reports indicated that the company was involved in misleading promotional practices, including claims linked to deceptive marketing of purported weight loss drugs similar to Novo Nordisk's Wegovy products. These practices caused significant concern regarding patient safety and hinted at a potential termination of Hims & Hers' partnership with Novo Nordisk.

When accurate information about these practices became public, investors faced substantial losses. The lawsuit aims to hold Hims & Hers accountable for its misleading statements and actions that have damaged investor interests.

How to Get Involved

Investors who believe they have suffered financial losses due to these circumstances are encouraged to take action by contacting The Schall Law Firm. Interested parties can reach out before August 25, 2025, to ensure their rights are safeguarded as part of this ongoing litigation. The law firm provides free consultations to discuss individual circumstances and outlines the steps involved in joining the class action.

Brian Schall, a representative of the law firm, is available at the firm’s office located at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067. Investors can also call directly at 310-301-3335 for guidance or visit the law firm's website at schallfirm.com for more detailed information.

Current Status of the Class Action

It is important to note that, as of now, the class has not yet been officially certified. This means that investors are currently not represented by an attorney unless they take proactive steps to join the lawsuit. If no action is taken, investors will remain as absent class members, possibly missing the opportunity for recovery.

Conclusion

The ongoing situation surrounding Hims & Hers Health, Inc. underscores critical issues in the accountability and transparency of publicly traded companies. As investor rights come under the spotlight, individuals affected during the specified class period have the opportunity to band together and possibly recover their losses through this significant legal action. The Schall Law Firm is dedicated to representing the voices of investors and pushing back against securities fraud, making their involvement a vital step towards justice and restitution for affected shareholders.